-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JcKLSoRZryrbJT1nMXsOK4hcjW72tL025Bzc/rFLuSG61LMmIi6WVxpcgSmiDMls D7Aza2pvZHcu4J/XKoU4zA== 0000873303-10-000025.txt : 20100610 0000873303-10-000025.hdr.sgml : 20100610 20100610132948 ACCESSION NUMBER: 0000873303-10-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100609 FILED AS OF DATE: 20100610 DATE AS OF CHANGE: 20100610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHASE ANTHONY R CENTRAL INDEX KEY: 0001223756 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 10889797 MAIL ADDRESS: STREET 1: 10307 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-354-5038 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-06-09 0 0000873303 AVI BIOPHARMA INC AVII 0001223756 CHASE ANTHONY R 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL WA 98021 1 0 0 0 Common Stock 2010-06-09 4 P 0 1000 1.399 A 345967 D Common Stock 2010-06-09 4 P 0 5600 1.4 A 351567 D Common Stock 2010-06-09 4 P 0 100 1.415 A 351667 D Common Stock 2010-06-09 4 P 0 6900 1.419 A 358567 D Common Stock 2010-06-09 4 P 0 700 1.4197 A 359267 D Common Stock 2010-06-09 4 P 0 100 1.4198 A 359367 D Common Stock 2010-06-09 4 P 0 300 1.4199 A 359667 D Common Stock 2010-06-09 4 P 0 31800 1.42 A 391467 D Common Stock Purchase Warrants 1.78 2010-02-25 2014-08-25 Common Stock 140000 350000 D Non-Qualified Stock Option (right to buy) 1.24 2011-04-20 2020-04-20 Common Stock 60000 60000 D Mr. Chase holds 350,000 warrants to purchase common stock. Each warrant can be exercised to purchase 4/10 (or 0.4) of a share of common stock. Thus, Mr. Chase's 350,000 warrants are exercisable to purchase 140,000 shares of common stock at $1.78 per share. Such options shall have a four-year vesting period commencing on the Grant Date, 1/4th of the shares vest and become exercisable on the earlier of one year after the Grant Date or the commencement of the next succeeding annual meeting of shareholders; 1/4th of the shares vest and become exercisable on the earlier of two years after the Grant Date or the commencement of the next succeeding annual meeting of shareholders, 1/4th of the shares vest and become exercisable on the earlier of three years after the Grant Date or the commencement of the next succeeding annual meeting of shareholders and 1/4th of the shares vest and become exercisable on the earlier of four years after the Grant Date or the commencement of the next succeeding annual meeting of shareholders. By: Melinda Miles For: Anthony Chase 2010-06-10 -----END PRIVACY-ENHANCED MESSAGE-----